Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SAM SHENG-SEN WENG

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1720038201
CMS profile
169189
Location
BETHLEHEM, PA

General Payments · PY2018–2019

$1,119.04

  • Reported across 60 records
  • CMS publication 2026-01-23

Latest program year · PY2019

$446.28

17 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2019 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $446.28 17

By paying entity

PY2019 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $340.14 10
Janssen Pharmaceuticals, Inc $38.72 3
Acerta Pharma LLC $36.72 2
E.R. Squibb & Sons, L.L.C. $17.42 1
Astellas Pharma US Inc $13.28 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $672.76 43
PY2019 $446.28 17

Payment records · PY2019 (17)

Sorted by paying entity, then date · as published by CMS

Program year 2019 2018 Record-level detail is published for PY2019; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Astellas Pharma US Inc $13.28 05/01/2019 Food and Beverage Undisputed 01/23/2026 655797527 CMS
AstraZeneca Pharmaceuticals LP $17.24 02/27/2019 Food and Beverage Undisputed 01/23/2026 685165416 CMS
AstraZeneca Pharmaceuticals LP $19.48 04/24/2019 Food and Beverage Undisputed 01/23/2026 685268573 CMS
E.R. Squibb & Sons, L.L.C. $17.42 01/23/2019 Food and Beverage Undisputed 01/23/2026 651302523 CMS
Janssen Pharmaceuticals, Inc $15.75 01/08/2019 Food and Beverage Undisputed 01/23/2026 659374655 CMS
Janssen Pharmaceuticals, Inc $11.09 02/07/2019 Food and Beverage Undisputed 01/23/2026 659374657 CMS
Janssen Pharmaceuticals, Inc $11.88 03/06/2019 Food and Beverage Undisputed 01/23/2026 659374659 CMS
Novo Nordisk Inc $13.59 01/09/2019 Food and Beverage Undisputed 01/23/2026 668803643 CMS
Novo Nordisk Inc $10.54 01/16/2019 Food and Beverage Undisputed 01/23/2026 668803641 CMS
Novo Nordisk Inc $12.68 03/12/2019 Food and Beverage Undisputed 01/23/2026 669484665 CMS
Novo Nordisk Inc $120.78 03/12/2019 Food and Beverage Undisputed 01/23/2026 703514315 CMS
Novo Nordisk Inc $9.51 03/20/2019 Food and Beverage Undisputed 01/23/2026 682836039 CMS
Novo Nordisk Inc $124.80 03/26/2019 Food and Beverage Undisputed 01/23/2026 703510143 CMS
Novo Nordisk Inc $11.77 05/21/2019 Food and Beverage Undisputed 01/23/2026 669581523 CMS
Novo Nordisk Inc $9.25 05/22/2019 Food and Beverage Undisputed 01/23/2026 682836053 CMS
Novo Nordisk Inc $17.22 06/18/2019 Food and Beverage Undisputed 01/23/2026 674450909 CMS
Novo Nordisk Inc $10.00 06/27/2019 Food and Beverage Undisputed 01/23/2026 674450911 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019
Source files
Dataset page · Bulk file · PY2018 , PY2019
Generated from
OP_DTL_GNRL_PGYR2019_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.